QA: Orgenesis Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001460602_2024_Orgenesis_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001460602, Orgenesis Inc

  xvar xval
0 AssetsCurrent 4,076,000
1 IntangibleAssetsNetIncludingGoodwill 8,586,000
2 PropertyPlantAndEquipmentNet 1,475,000
3 remainder_Assets 415,000
4 LiabilitiesCurrent 16,407,000
5 LiabilitiesNoncurrent 19,128,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 14,219,907
8 SellingGeneralAndAdministrativeExpense 46,917,343
9 ResearchAndDevelopmentExpense 8,993,662
10 remainder_Expenses 4,851,853
11 remainder_Revenues 12,011,264
12 remainder_NetIncome -6,919,812
13 remainder_ComprehensiveNetIncome -2,182,031
  yvar yval
0 Assets 14,552,000
1 Liabilities 35,535,000
2 Expenses 74,982,765
3 Revenues 12,011,264
4 StockholdersEquity -20,983,000
5 NetIncome -69,891,313
6 ComprehensiveNetIncome -70,982,328
7 BaseVar 73,091,436
8 EconomicCapitalRatiobeforeLimitedLiability -4.66
9 EconomicCapitalRatio 0.248

Edgar->Model Mapping

Feature Distribution

Change over Time